GlassScriptPhysician profile
John P Nolan
NPI 1417953258
$1,602.30
in general payments reported to CMS, 2019-2025
22 companies · $98.62 in 2025
The $98.62 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $499 · 2020: $68.58 · 2021: $72.12 · 2022: $166 · 2023: $308 · 2024: $389 · 2025: $98.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453 · Consulting Fee: $344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.92 |
| Consulting Fee | $343.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $343.50 | 2024 | Combogesic IV |
| Zimmer Biomet Holdings, INC. | $185.30 | 2021-2023 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $159.29 | 2019-2022 | |
| Pacira Therapeutics, INC. | $141.03 | 2019-2020 | |
| Abbvie INC. | $133.15 | 2023-2024 | |
| Stryker Corporation | $118.14 | 2019 | |
| Globus Medical, INC. | $98.62 | 2025 | Senza |
| Ferring Pharmaceuticals INC. | $77.38 | 2019-2023 | Euflexxa |
| Heraeus Medical, LLC. | $43.48 | 2023 | Palacos |
| Integra Lifesciences Corporation | $36.65 | 2019 | |
| Davol INC. | $31.27 | 2023 | Arista Ah Flexitip |
| Sanofi-Aventis U.S. LLC | $28.45 | 2019-2020 | |
| Smith+Nephew, INC. | $27.89 | 2019-2021 | |
| Pfizer INC. | $26.78 | 2019-2021 | |
| Boston Scientific Corporation | $22.13 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $20.63 | 2022 | |
| Next Science LLC | $20.55 | 2023 | Blastx, Surgx, Xperience |
| Zyla Life Sciences, INC. | $19.36 | 2019 | |
| Avanos Medical | $19.00 | 2022 | |
| Vericel Corporation | $17.34 | 2019 | |
| Medacta USA, INC. | $16.55 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.81 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.